Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-11

FDA Approved: PIRFENIDONE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved a supplemental application for pirfenidone from Amneal Pharmaceuticals NY LLC, supporting a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

SUPPL AP for PIRFENIDONE (PIRFENIDONE)